<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Сиофор.Вопрос к профи:-)? on Психиатрия и психореаниматология</title><link>https://psychoreanimatology.org/forum/voprosy-i-repliki/3296-siofor-vopros-k-profi/</link><description>Recent content in Сиофор.Вопрос к профи:-)? on Психиатрия и психореаниматология</description><generator>Hugo</generator><language>ru-RU</language><lastBuildDate>Thu, 14 Apr 2011 23:11:37 +0400</lastBuildDate><atom:link href="https://psychoreanimatology.org/forum/voprosy-i-repliki/3296-siofor-vopros-k-profi/index.xml" rel="self" type="application/rss+xml"/><item><title>Re: Сиофор.Вопрос к профи:-)????</title><link/><pubDate>Thu, 14 Apr 2011 23:11:37 +0400</pubDate><guid/><description>&lt;blockquote&gt;&#10;&lt;p&gt;Sonia пишет:&lt;br&gt;&#10;Сиофор может вызвать чрезмерную слабость, если слишком быстро наращивать дозировку. А так препарат без особых побочек. Довольно значимо снижает аппетит.&lt;/p&gt;&#10;&lt;p&gt;Кстати, для тех, кто применяет антигистаминные препараты я нашла любопытный вариант это &lt;a href="http://en.wikipedia.org/wiki/Betahistine"&gt;бетагистин&lt;/a&gt;.&lt;/p&gt;&#10;&lt;blockquote&gt;&#10;&lt;p&gt;A new use for betahistine may be in the field of obesity management. Dr Nir Barak of the Rabin Medical Centre in Tel Aviv has undertaken trials[3] and it is reported (Telegraph, UK, 19 February 2007) that volunteers lost more than 1.5 kg/week over twelve weeks and experienced a distaste for fatty foods.&lt;br&gt;&#10;A recent Phase II clinical trial of the new drug in the U.S. suggests that women under the age of 50 who took Histalean (Betahistine) for 12 weeks lost 7 times the weight of those taking a placebo. What&amp;rsquo;s most important to the researchers involved is that none of the 281 patients, males and females aged 18–65, complained of any serious side effects. The recent results were based on a double-blind, placebo-controlled study on people with a Body Mass Index ranging from 30 to 40. (A BMI of 30 and above indicate obesity.) The study was conducted at 19 investigation sites across the U.S. over a 12 week treatment period. The subgroup of high-dose Histalean (Betahistine)-treated women lost an average of 2.91% of their weight versus placebo group which lost only 0.4 %.[4]&lt;br&gt;&#10;Betahistine is being studied for the treatment of atypical depression at dosages from 50–300 mg/day due to its ability to antagonise H3 receptors and thus increase the release of serotonin and dopamine from nerve endings into the synaptic cleft.[5]&lt;br&gt;&#10;[edit]&lt;/p&gt;&#10;&lt;/blockquote&gt;&#10;&lt;p&gt;Бетагистин можно было бы принимать, например, с Ремероном, амитриптилином и др. препаратами, блокирующими Н1 рецепторы. Как Вы считаете?&lt;/p&gt;&#10;&lt;/blockquote&gt;</description></item><item><title>Re: Сиофор.Вопрос к профи:-)????</title><link/><pubDate>Thu, 14 Apr 2011 19:49:05 +0400</pubDate><guid/><description>&lt;p&gt;Сиофор может вызвать чрезмерную слабость, если слишком быстро наращивать дозировку. А так препарат без особых побочек. Довольно значимо снижает аппетит.&lt;/p&gt;&#10;&lt;p&gt;Кстати, для тех, кто применяет антигистаминные препараты я нашла любопытный вариант это &lt;a href="http://en.wikipedia.org/wiki/Betahistine"&gt;бетагистин&lt;/a&gt;.&lt;/p&gt;&#10;&lt;blockquote&gt;&#10;&lt;p&gt;A new use for betahistine may be in the field of obesity management. Dr Nir Barak of the Rabin Medical Centre in Tel Aviv has undertaken trials[3] and it is reported (Telegraph, UK, 19 February 2007) that volunteers lost more than 1.5 kg/week over twelve weeks and experienced a distaste for fatty foods.&lt;br&gt;&#10;A recent Phase II clinical trial of the new drug in the U.S. suggests that women under the age of 50 who took Histalean (Betahistine) for 12 weeks lost 7 times the weight of those taking a placebo. What&amp;rsquo;s most important to the researchers involved is that none of the 281 patients, males and females aged 18–65, complained of any serious side effects. The recent results were based on a double-blind, placebo-controlled study on people with a Body Mass Index ranging from 30 to 40. (A BMI of 30 and above indicate obesity.) The study was conducted at 19 investigation sites across the U.S. over a 12 week treatment period. The subgroup of high-dose Histalean (Betahistine)-treated women lost an average of 2.91% of their weight versus placebo group which lost only 0.4 %.[4]&lt;br&gt;&#10;Betahistine is being studied for the treatment of atypical depression at dosages from 50–300 mg/day due to its ability to antagonise H3 receptors and thus increase the release of serotonin and dopamine from nerve endings into the synaptic cleft.[5]&lt;br&gt;&#10;[edit]&lt;/p&gt;&#10;&lt;/blockquote&gt;</description></item><item><title>Сиофор.Вопрос к профи:-)?</title><link/><pubDate>Thu, 14 Apr 2011 19:29:44 +0400</pubDate><guid/><description>&lt;p&gt;На сегодняшний день никакие лекарства не принимаю уже пол года. Состояние в норме. Можно ли попить сиофор с целью снижения веса( одни диеты что то не особо помогают)???? Какие побочные последствия можно получить?Сахар в норме. Специалисты врачи подскажите, пожалуйста. Всем заранее спасибо&lt;/p&gt;</description></item></channel></rss>